Advertisement

Prevalence of Hypovitaminosis D in Cardiovascular Diseases (from the National Health and Nutrition Examination Survey 2001 to 2004)

Published:September 26, 2008DOI:https://doi.org/10.1016/j.amjcard.2008.06.067
      This cross-sectional study examined the burden of cardiovascular diseases (CVDs) using serum 25-hydroxyvitamin D (25[OH]D) and prevalence of hypovitaminosis D in adults with CVDs using data from NHANES 2001 to 2004. Serum 25(OH)D levels were divided into 3 categories (≥30, 20 to 29, and <20 ng/ml), and hypovitaminosis D was defined as vitamin D <30 ng/ml. Of 8,351 adults who had 25(OH)D measured, mean 25(OH)D was 24.3 ng/ml, and the prevalence of hypovitaminosis D was 74%. The burden of CVDs increased with lower 25(OH)D categories, with 5.3%, 6.7%, and 7.3% coronary heart disease; 1.5%, 2.4%, and 3.2% heart failure; 2.5%, 2.0%, and 3.2% stroke; and 3.6%, 5.0%, and 7.7% peripheral arterial disease. Across all CVDs, hypovitaminosis D was more common in blacks than Hispanics or whites. Compared with persons at low risk for CVDs (68%), it was more prevalent in those at high risk (75%; odds ratio [OR] 1.32, 95% confidence interval [CI] 1.05 to 1.67), with coronary heart disease (77%; OR 1.48, 95% CI 1.14 to 1.91), and both coronary heart disease and heart failure (89%; OR 3.52, 95% CI 1.58 to 7.84) after controlling for age, race, and gender. In conclusion, hypovitaminosis D was highly prevalent in US adults with CVDs, particularly those with both coronary heart disease and heart failure.
      To read this article in full you will need to make a payment

      References

        • Zittermann A.
        Vitamin D in preventive medicine: are we ignoring the evidence?.
        Br J Nutr. 2003; 89: 552-572
        • Zadshir A.
        • Tareen N.
        • Pan D.
        • Norris K.
        • Martins D.
        The prevalence of hypovitaminosis D among US adults: data from the NHANES III.
        Ethn Dis. 2005; 15: S5-S101
        • Lind L.
        • Hanni A.
        • Lithell H.
        • Hvarfner A.
        • Sorensen O.H.
        • Ljunghall S.
        Vitamin D is related to blood pressure and other cardiovascular risk factors in middle-aged men.
        Am J Hypertens. 1995; 8: 894-901
        • Martins D.
        • Wolf M.
        • Pan D.
        • Zadshir A.
        • Tareen N.
        • Thadhani R.
        • Felsenfeld A.
        • Levine B.
        • Mehrotra R.
        • Norris K.
        Prevalence of cardiovascular risk factors and the serum levels of 25-hydroxyvitamin D in the United States: data from the Third National Health and Nutrition Examination Survey.
        Arch Intern Med. 2007; 167: 1159-1165
        • Fahrleitner A.
        • Dobnig H.
        • Obernosterer A.
        • Pilger E.
        • Leb G.
        • Weber K.
        • Kudlacek S.
        • Obermayer-Pietsch B.M.
        Vitamin D deficiency and secondary hyperparathyroidism are common complications in patients with peripheral arterial disease.
        J Gen Intern Med. 2002; 17: 663-669
        • Poole K.E.
        • Loveridge N.
        • Barker P.J.
        • Halsall D.J.
        • Rose C.
        • Reeve J.
        • Warburton E.A.
        Reduced vitamin D in acute stroke.
        Stroke. 2006; 37: 243-245
        • Scragg R.
        • Jackson R.
        • Holdaway I.M.
        • Lim T.
        • Beaglehole R.
        Myocardial infarction is inversely associated with plasma 25-hydroxyvitamin D3 levels: a community-based study.
        Int J Epidemiol. 1990; 19: 559-563
        • Zittermann A.
        • Schleithoff S.S.
        • Tenderich G.
        • Berthold H.K.
        • Korfer R.
        • Stehle P.
        Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?.
        J Am Coll Cardiol. 2003; 41: 105-112
        • Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS)
        National Health and Nutrition Examination survey data.
        (Hyattsville, MD: U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. 2001–2004.) (Accessed December 17, 2007)
        • Orchard T.J.
        • Strandness Jr, D.E.
        Assessment of peripheral vascular disease in diabetes.
        Diabetes Care. 1993; 16: 1199-1209
        • Levey A.S.
        • Coresh J.
        • Greene T.
        • Stevens L.A.
        • Zhang Y.L.
        • Hendriksen S.
        • Kusek J.W.
        • Van L.F.
        Using standardized serum creatinine values in the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate.
        Ann Intern Med. 2006; 145: 247-254
        • Li Y.C.
        • Kong J.
        • Wei M.
        • Chen Z.F.
        • Liu S.Q.
        • Cao L.P.
        1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system.
        J Clin Invest. 2002; 110: 229-238
        • O'Connell T.D.
        • Berry J.E.
        • Jarvis A.K.
        • Somerman M.J.
        • Simpson R.U.
        1,25-Dihydroxyvitamin D3 regulation of cardiac myocyte proliferation and hypertrophy.
        Am J Physiol. 1997; 272: H1751-H1758
        • Mitsuhashi T.
        • Morris Jr., R.C.
        • Ives H.E.
        1,25-Dihydroxyvitamin D3 modulates growth of vascular smooth muscle cells.
        J Clin Invest. 1991; 87: 1889-1895
        • Perkovic V.
        • Hewitson T.D.
        • Kelynack K.J.
        • Martic M.
        • Tait M.G.
        • Becker G.J.
        Parathyroid hormone has a prosclerotic effect on vascular smooth muscle cells.
        Kidney Blood Press Res. 2003; 26: 27-33
        • Rigby W.F.
        • Denome S.
        • Fanger M.W.
        Regulation of lymphokine production and human T lymphocyte activation by 1,25-dihydroxyvitamin D3.
        J Clin Invest. 1987; 79: 1659-1664
        • Autier P.
        • Gandini S.
        Vitamin D supplementation and total mortality: a meta-analysis of randomized controlled trials.
        Arch Intern Med. 2007; 167: 1730-1737
        • Zittermann A.
        • Fischer J.
        • Schleithoff S.S.
        • Tenderich G.
        • Fuchs U.
        • Koerfer R.
        Patients with congestive heart failure and healthy controls differ in vitamin D-associated lifestyle factors.
        Int J Vitam Nutr Res. 2007; 77: 280-288
        • Forman J.P.
        • Giovannucci E.
        • Holmes M.D.
        • Bischoff-Ferrari H.A.
        • Tworoger S.S.
        • Willett W.C.
        • Curhan G.C.
        Plasma 25-hydroxyvitamin D levels and risk of incident hypertension.
        Hypertension. 2007; 49: 1063-1069
        • Wang T.J.
        • Pencina M.J.
        • Booth S.L.
        • Jacques P.F.
        • Ingelsson E.
        • Lanier K.
        • Benjamin E.J.
        • D'Agostino R.B.
        • Wolf M.
        • Vasan R.S.
        Vitamin D deficiency and risk of cardiovascular disease.
        Circulation. 2008; 117: 503-511